| 000 | 01457 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516193435.0 | ||
| 264 | 0 | _c20141203 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1532-432X | ||
| 024 | 7 |
_a10.3109/03630269.2013.869229 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKosaryan, Mehrnoush | |
| 245 | 0 | 0 |
_aReport on patients with non transfusion-dependent β-thalassemia major being treated with hydroxyurea attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013. _h[electronic resource] |
| 260 |
_bHemoglobin _c2014 |
||
| 300 |
_a115-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntisickling Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBlood Cell Count |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 | _aErythrocyte Indices |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHematocrit |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyurea _xtherapeutic use |
| 650 | 0 | 4 | _aIran |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_abeta-Globins _xgenetics |
| 650 | 0 | 4 |
_abeta-Thalassemia _xdrug therapy |
| 700 | 1 | _aKarami, Hossein | |
| 700 | 1 | _aZafari, Mandana | |
| 700 | 1 | _aYaghobi, Negar | |
| 773 | 0 |
_tHemoglobin _gvol. 38 _gno. 2 _gp. 115-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/03630269.2013.869229 _zAvailable from publisher's website |
| 999 |
_c23492757 _d23492757 |
||